 MONTREAL, Nov. 16, 2020 GLOBE NEWSWIRE -- Theratechnologies Inc. Theratechnologies TSX: TH NASDAQ: THTX, a biopharmaceutical company focused on the development and commercialization of innovative therapies, today highlighted new data on the mechanism of effect of tesamorelin presented in an oral presentation given today by Lindsay T. Fourman, M.D., of the Metabolism Unit, Department of Medicine, Massachusetts General Hospital, at The Liver Meeting 2020 of the American Association for the Study of Liver Diseases AASLD. 